Mr. Andre Godin reports

NEUROBIOPHARM'S SHAREHOLDERS APPROVE ARRANGEMENT WITH NEPTUNE

Shareholders of NeuroBioPharm Inc., a subsidiary of Neptune Technologies & Bioressources Inc., approved a resolution on Feb. 12, 2015, authorizing the previously announced plan of arrangement, providing for, among other things, the indirect acquisition by Neptune of all of the issued and outstanding shares of NeuroBio.

The arrangement resolution required the approval of at least two-thirds of the votes cast by the shareholders holding all classes of shares of NeuroBio, voting separately as classes, in each case present in person or represented by proxy at the special meeting of shareholders held on Feb. 12, 2015.

The arrangement resolution was approved by: (i) 96.95 per cent of the votes cast by shareholders holding Class A shares of NeuroBio, (ii) 90 per cent of the votes cast by shareholders holding Class B shares of NeuroBio, (iii) 90 per cent of the votes cast by shareholders holding Class G shares of NeuroBio, and (iv) 90 per cent of the votes cast by shareholders holding Class H shares of NeuroBio.

The arrangement is also subject to the approval of the Superior Court of Quebec at a final hearing which is scheduled to be held on Feb. 16, 2015, at the Montreal Courthouse in Montreal, Que., at 9:15 a.m. (Montreal time) or as soon thereafter as counsel may be heard. It is anticipated that the arrangement will be completed shortly thereafter once all closing conditions have been satisfied or waived, including, without limitation, court approval set forth above.

We seek Safe Harbor.